Bank of America
LYEL icon

Bank of America’s Lyell Immunopharma LYEL Stock Holding History

Bank of America’s Portfolio LYEL Stock Details LYEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$668K Buy
33,321
+25,276
+314% +$591K ﹤0.01% 4737
2025
Q4 		$248K Buy
8,045
+3,366
+72% +$75.3K ﹤0.01% 5236
2025
Q3 		$76K Sell
4,679
-19,079
-80% -$218K ﹤0.01% 6708
2025
Q2 		$210K Buy
23,758
+19,054
+405% +$174K ﹤0.01% 6164
2025
Q1 		$50.6K Sell
4,704
-3,411
-42% -$41.8K ﹤0.01% 6740
2024
Q4 		$104K Sell
8,115
-323
-4% -$6.4K ﹤0.01% 6381
2024
Q3 		$233K Buy
8,438
+1,295
+18% +$38.1K ﹤0.01% 5923
2024
Q2 		$207K Sell
7,143
-3,831
-35% -$182K ﹤0.01% 5866
2024
Q1 		$489K Sell
10,974
-72,055
-87% -$3.09M ﹤0.01% 5361
2023
Q4 		$3.22M Buy
83,029
+46,624
+128% +$1.68M ﹤0.01% 3936
2023
Q3 		$1.07M Buy
36,405
+11,894
+49% +$565K ﹤0.01% 4772
2023
Q2 		$1.56M Sell
24,511
-12,429
-34% -$688K ﹤0.01% 4425
2023
Q1 		$1.74M Buy
36,940
+4,816
+15% +$258K ﹤0.01% 4471
2022
Q4 		$2.23M Buy
32,124
+19,631
+157% +$1.95M ﹤0.01% 4156
2022
Q3 		$1.83M Buy
12,493
+4,784
+62% +$648K ﹤0.01% 4361
2022
Q2 		$1M Sell
7,709
-1,633
-17% -$167K ﹤0.01% 4902
2022
Q1 		$943K Buy
9,342
+4,984
+114% +$604K ﹤0.01% 5330
2021
Q4 		$675K Buy
4,358
+4,256
+4,173% +$949K ﹤0.01% 5616
2021
Q3 		$30K Sell
102
-3,121
-97% -$935K ﹤0.01% 7261
2021
Q2 		$1.05M Buy
+3,223
New +$1.06M ﹤0.01% 4866

Other funds holding LYEL

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
GP
GSK plc London $599M AUM
FCMI
Foresite Capital Management IV Larkspur, California $237M AUM 107.53% 1-Year Est. Return
OPL
Orland Properties Ltd Road Town, Tortola, British Virgin Islands $267M AUM 5.05% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
AC
Almitas Capital Santa Monica, California $443M AUM 42.36% 1-Year Est. Return
FCMV
Foresite Capital Management V Larkspur, California $271M AUM 309.87% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Bank of America's LYEL Position: Q1 2026 in Review

Bank of America increased its Lyell Immunopharma (LYEL) stake by 314% in Q1 2026, buying an estimated $591K and bringing the position to 33,321 shares worth $668K. The position accounts for ﹤0.01% of the portfolio, ranked #4737.

Bank of America first reported a position in LYEL in Q2 2021 and has held it in 20 quarters since. The position peaked at $3.22M in Q4 2023. 74 funds tracked by Wall St. Rank hold LYEL as of Q1 2026.

  • Bank of America held 33,321 shares of Lyell Immunopharma worth $668K as of Q1 2026.
  • Bank of America bought 25,276 Lyell Immunopharma shares in Q1 2026, an estimated $591K.
  • Lyell Immunopharma made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #4737 holding.
  • Bank of America first reported a position in Lyell Immunopharma in Q2 2021 and has held it in 20 quarters since.
  • Bank of America's Lyell Immunopharma position peaked at $3.22M in Q4 2023.
  • 74 funds tracked by Wall St. Rank held Lyell Immunopharma as of Q1 2026.

Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.